retatrutide approval status 2025 retatrutide fda approval HAS NOT BEEN APPROVED YET & CURRENTLY IN PHASE III CLINICAL TRIALS⛔️ is not currently FDA-approved, as it is in Phase III clinical trials with anticipated completion in 2025–2026 and Retatrutide Phase 3: 60% Achieved
Description
When a large number of individuals file similar cases with similar complaints, they are often consolidated to help expedite the legal process
Do not freeze reconstituted peptide, as the freeze-thaw cycle damages protein structure
Most patients reach therapeutic doses (1.02.4 mg weekly) over 1620 weeks
If the label says "5mg lyophilized retatrutide," your vial contains 5 milligrams of peptide in powder form
It is to keep skin feeling cared for while change is happening
